tradingkey.logo
tradingkey.logo
Search

Stoke Therapeutics Inc

STOK
Add to Watchlist
25.770USD
-0.340-1.30%
Market hours 09/24, 10:20ET
1.60BMarket Cap
LossP/E TTM

STOK Financials

See Stoke Therapeutics Inc's financials through an all-in-one data dashboard designed for smart investors. This provides you with financial analysis by organizing complex financial statements into customizable views. Access the latest annual financial report or break down performance quarter-by-quarter using the income statement, balance sheet, and cash flow statement. With real-time financial indicators at your fingertips, monitoring a company's market health over time has never been easier.

Key Financial Ratios

Market Cap
1.60B
Dividend TTM
0.00
P/E TTM
-9.01
EPS TTM
-2.86
Revenue
184.42M
Net Profit
-88.98M
ROE
-45.58%
ROA
-39.94%

Stoke Therapeutics Inc Earnings Date

Latest Release
Aug 3, 2026
EPS / Forecast
-0.93/-0.80
Revenue / Forecast
9.32M/6.04M

Financial Statement Highlights

Quarterly
Quarterly+Annual
Quarterly
Annual
FY2026Q2
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
Financial Indicators
EPS
-131.93%-0.93
-140.64%-0.79
-432.58%-0.98
-39.47%-0.65
12.66%-0.40
442.07%1.95
69.36%-0.18
15.39%-0.47
33.58%-0.46
-7.60%-0.57
7.84%-0.60
---0.55
---0.69
---0.53
---0.65
---1.95
----
----
----
----
Revenue
-32.51%9.32M
-96.07%6.23M
-93.80%1.40M
117.25%10.63M
186.01%13.82M
3661.12%158.57M
707.07%22.61M
47.94%4.89M
294.72%4.83M
-18.17%4.22M
-14.26%2.80M
13.87%3.31M
-176.79%-2.48M
71.73%5.15M
--3.27M
--2.91M
--3.23M
--3.00M
--0.00
----
Net Profit
-162.39%-61.62M
-144.30%-50.00M
-452.70%-57.93M
-45.09%-38.35M
8.61%-23.48M
527.99%112.88M
61.12%-10.48M
-7.69%-26.43M
16.18%-25.70M
-16.98%-26.37M
-5.08%-26.96M
6.01%-24.54M
-24.35%-30.65M
8.54%-22.55M
-4.94%-25.66M
-15.55%-26.11M
-12.22%-24.65M
-46.78%-24.65M
-67.90%-24.45M
-65.13%-22.60M
Net Margin
-288.79%-660.78%
-1227.67%-802.75%
-8814.95%-4132.24%
33.21%-360.68%
68.05%-169.96%
111.38%71.19%
95.18%-46.35%
27.21%-540.05%
---531.88%
-42.96%-625.57%
-22.55%-962.10%
---741.90%
----
---437.60%
---785.04%
---825.35%
----
----
----
----
Gross Margin
0.00%100.00%
0.00%100.00%
0.00%100.00%
0.00%100.00%
0.00%100.00%
0.00%100.00%
0.00%100.00%
0.00%100.00%
--100.00%
0.00%100.00%
0.00%100.00%
--100.00%
----
--100.00%
--100.00%
--100.00%
----
----
----
----
Revenue
-32.51%9.32M
-96.07%6.23M
-93.80%1.40M
117.25%10.63M
186.01%13.82M
3661.12%158.57M
707.07%22.61M
47.94%4.89M
294.72%4.83M
-18.17%4.22M
-14.26%2.80M
13.87%3.31M
-176.79%-2.48M
71.73%5.15M
--3.27M
--2.91M
--3.23M
--3.00M
--0.00
----
Operating profit
-139.67%-65.43M
-148.02%-53.42M
-350.00%-61.44M
-43.62%-43.09M
6.96%-27.30M
492.08%111.24M
53.85%-13.65M
-10.17%-30.00M
11.79%-29.34M
-14.91%-28.37M
-8.87%-29.59M
-0.32%-27.23M
-31.79%-33.26M
0.42%-24.69M
-10.80%-27.18M
-19.68%-27.15M
-14.57%-25.24M
-47.35%-24.80M
-68.15%-24.53M
-65.44%-22.68M
Net Profit
-162.39%-61.62M
-144.30%-50.00M
-452.70%-57.93M
-45.09%-38.35M
8.61%-23.48M
527.99%112.88M
61.12%-10.48M
-7.69%-26.43M
16.18%-25.70M
-16.98%-26.37M
-5.08%-26.96M
6.01%-24.54M
-24.35%-30.65M
8.54%-22.55M
-4.94%-25.66M
-15.55%-26.11M
-12.22%-24.65M
-46.78%-24.65M
-67.90%-24.45M
-65.13%-22.60M
Current assets
19.47%322.54M
-2.41%366.68M
31.34%305.70M
7.42%272.44M
-9.10%269.97M
94.40%375.74M
8.09%232.76M
10.26%253.61M
20.62%296.99M
-28.48%193.28M
-11.77%215.34M
-13.07%230.02M
-14.85%246.23M
-11.62%270.24M
6.48%244.07M
8.03%264.60M
11.12%289.16M
11.07%305.77M
-22.02%229.22M
25.31%244.93M
Total current liabilities
8.41%41.93M
-8.68%40.81M
44.49%57.88M
-16.32%41.73M
-13.08%38.68M
25.55%44.69M
29.97%40.06M
97.87%49.87M
103.76%44.50M
12.89%35.59M
-1.83%30.82M
-12.48%25.20M
-21.02%21.84M
37.64%31.53M
83.17%31.39M
142.30%28.80M
237.31%27.65M
274.88%22.91M
50.01%17.14M
76.45%11.88M
Total assets
2.46%393.97M
8.94%443.28M
54.09%418.43M
22.82%360.26M
24.94%384.51M
98.31%406.89M
18.92%271.56M
22.27%293.32M
19.79%307.76M
-27.19%205.18M
-10.83%228.34M
-13.59%239.89M
-14.77%256.92M
-10.81%281.80M
7.20%256.07M
9.40%277.63M
13.98%301.43M
13.28%315.94M
-19.82%238.87M
26.93%253.77M
Total liabilities
-2.31%48.42M
-14.81%48.40M
55.12%65.98M
-14.78%52.16M
-23.80%49.56M
-12.38%56.81M
-38.16%42.53M
-8.50%61.21M
-2.51%65.05M
-4.61%64.84M
-3.43%68.78M
-8.97%66.89M
-13.46%66.72M
-10.51%67.97M
237.72%71.22M
351.98%73.48M
721.94%77.11M
1078.97%75.96M
78.00%21.09M
119.70%16.26M
Total equity
3.17%345.55M
12.80%394.88M
53.90%352.46M
32.74%308.11M
38.00%334.94M
149.44%350.07M
43.53%229.02M
34.17%232.11M
27.61%242.71M
-34.37%140.34M
-13.68%159.56M
-15.26%173.00M
-15.21%190.19M
-10.90%213.82M
-15.12%184.85M
-14.05%204.14M
-12.05%224.32M
-11.92%239.98M
-23.87%217.78M
23.36%237.51M
Net operating income
-122.58%-56.59M
-145.96%-60.58M
-31.31%-30.45M
-40.49%-30.37M
-45.46%-25.42M
636.62%131.83M
-12.32%-23.19M
-25.22%-21.61M
19.83%-17.48M
-15.03%-24.57M
7.71%-20.65M
21.74%-17.26M
-9.39%-21.80M
-165.73%-21.36M
-37.61%-22.37M
-50.22%-22.06M
-25.88%-19.93M
261.36%32.49M
-48.73%-16.26M
-35.03%-14.68M
Net investment
106.07%9.02M
271.88%50.69M
-7555.56%-61.06M
130.31%9.09M
-68.19%-148.48M
36.48%13.63M
-94.46%819.00K
-305.27%-30.00M
-476.08%-88.28M
-81.18%9.99M
-34.32%14.77M
-78.27%14.62M
15977.40%23.47M
139.10%53.09M
90.64%22.49M
1377.81%67.26M
100.18%146.00K
-66459.80%-135.78M
13207.78%11.80M
-1856.88%-5.26M
Net financing
245.13%1.91M
6037.34%84.33M
16157.22%92.34M
-61.76%3.12M
-99.54%554.00K
-19.98%1.37M
-92.26%568.00K
1351.78%8.16M
251254.17%120.65M
-96.19%1.72M
16976.74%7.34M
29.49%562.00K
-98.60%48.00K
5.99%45.05M
-74.85%43.00K
6.37%434.00K
2054.09%3.42M
7685.16%42.51M
-99.84%171.00K
-39.38%408.00K

Revenue

By Business

Period:
No Data

By Region

Period:
No Data

FAQs

What is the total revenue of Stoke Therapeutics Inc?

According to Stoke Therapeutics Inc's FY2025 earnings report, its total revenue reached 184.42M, with a year-on-year change of 36.55M.

What are the current assets of Stoke Therapeutics Inc?

According to Stoke Therapeutics Inc's FY2025 earnings report, its current assets were 305.70M, with a year-on-year change of 31.34.

What are the total assets of Stoke Therapeutics Inc?

According to Stoke Therapeutics Inc's FY2025 earnings report, its total assets of Stoke Therapeutics Inc were 418.43M, with a year-on-year change of 54.09.

What are the total liabilities of Stoke Therapeutics Inc?

According to Stoke Therapeutics Inc's FY2025 earnings report, its total liabilities of Stoke Therapeutics Inc were 65.98M, with a year-on-year change of 55.12.

What is the total equity of Stoke Therapeutics Inc?

According to Stoke Therapeutics Inc's FY2025 earnings report, its total equity of Stoke Therapeutics Inc was 352.46M, with a year-on-year change of 53.90.

What is the net operating income of Stoke Therapeutics Inc?

According to Stoke Therapeutics Inc's FY2025 earnings report, its net operating income of Stoke Therapeutics Inc was -20.59M, with a year-on-year change of 79.69.

What is the net investment of Stoke Therapeutics Inc?

According to Stoke Therapeutics Inc's FY2025 earnings report, its net investment of Stoke Therapeutics Inc was -186.81M, with a year-on-year change of -73.82.

What is the net financing of Stoke Therapeutics Inc?

According to Stoke Therapeutics Inc's FY2025 earnings report, its net financing of Stoke Therapeutics Inc was 97.39M, with a year-on-year change of -25.71.

What is the Earnings Per Share (EPS) of Stoke Therapeutics Inc?

According to Stoke Therapeutics Inc's FY2025 earnings report, its Earnings Per Share (EPS) was -0.12, with a year-on-year change of 92.94.

What is the net income of Stoke Therapeutics Inc?

According to Stoke Therapeutics Inc's FY2025 earnings report, its net income was -6.88M, with a year-on-year change of 92.26.

What is the net margin of Stoke Therapeutics Inc?

According to Stoke Therapeutics Inc's FY2025 earnings report, its net profit margin was -3.73, with a year-on-year change of 98.47.

What is the Return on Equity (ROE) of Stoke Therapeutics Inc?

According to Stoke Therapeutics Inc's FY2025 earnings report, its Return on Equity (ROE) was -2.37, with a year-on-year change of 94.83.

What is the Return on Assets (ROA) of Stoke Therapeutics Inc?

According to Stoke Therapeutics Inc's FY2025 earnings report, its Return on Assets (ROA) was -2.00, with a year-on-year change of 94.39.

What is the operating profit of Stoke Therapeutics Inc?

According to Stoke Therapeutics Inc's FY2025 earnings report, its operating profit was -20.59M, with a year-on-year change of 79.69.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.